LEI record
· United StatesALSERES PHARMACEUTICALS, INC.
ALSERES PHARMACEUTICALS, INC. in DOVER — Lapsed LEI 549300D10MMN3WI6P316, registered 2014.
Changes recorded by LEIatlas since 6 Jul 2026: renamed from “Alseres Pharmaceuticals, Inc.” to “ALSERES PHARMACEUTICALS, INC.” on 25 Jul 2026. GLEIF publishes only the current record.
- Legal form
- Corporation
- Jurisdiction
- United States
- Registered
- 5 Dec 2014
- Next renewal
- 3 Dec 2015
Reference data
Identity
- LEI
- 549300D10MMN3WI6P316
- ISIN
- US0211522026
- Legal form
- CorporationXTIQ
- Registration authority
- RA000602entity ID 781874
- Legal address
- C/O REGISTERED AGENT SOLUTIONS, INC., 838 WALKER ROAD, SUITE 21-2, DOVER, 19904, US
- Location
- DOVER, Delaware, United States
- HQ address
- 275 Grove Street, Suite 2-400, Auburndale, Newton, US
- Initial registration
- 5 Dec 2014
- Last updated
- 24 Jul 2026
- Managing LOU (issuer)
- Bloomberg Finance L.P.5493001KJTIIGC8Y1R12
Level 2 · who owns whom
Corporate structure
Securities & codes
Securities and identifiers
- Securities (ISIN) · 1
- US0211522026
- An ISIN (ISO 6166) identifies a single security, such as a share or a bond; the LEI identifies the legal entity behind it. In GLEIF’s ISIN-to-LEI relationship file, ALSERES PHARMACEUTICALS, INC. is the issuer of this ISIN. Any of them can be looked up with the ISIN lookup or directly at leiatlas.com/isin/US0211522026, which resolves to this page.
The archive · 2 versions
Change history
- 25 Jul 2026 – current
- Legal name: Alseres Pharmaceuticals, Inc.→ALSERES PHARMACEUTICALS, INC.
- Legal address: C/O The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street→C/O REGISTERED AGENT SOLUTIONS, INC., 838 WALKER ROAD, SUITE 21-2
- City: Wilmington→DOVER
- 6 Jul 2026 – 25 Jul 2026First recorded version.
What this means
What the record says about ALSERES PHARMACEUTICALS, INC.
ALSERES PHARMACEUTICALS, INC. is a Corporation in DOVER, United States with 1 ISIN-identified security mapped to its LEI, which is how regulators tie a traded instrument to the issuer behind it.
The LEI has been on record for 11 years, since 5 Dec 2014. That is about 4 years earlier than the median LEI in United States, which dates from 2019 — an early adopter by local standards.
Annual re-validation is 3992 days overdue: it fell due 3 Dec 2015. An LEI that is not re-validated lapses, which does not invalidate it but marks the reference data as unverified.
This archive holds 2 versions of the record. The most recent change was on 25 Jul 2026 and altered the legal name, legal address, city; the oldest version we hold dates from 6 Jul 2026. GLEIF publishes only the current state, so superseded values are not available from the source.
The LEI is issued and maintained by Bloomberg Finance L.P., one of the Local Operating Units accredited by GLEIF.
Beyond the LEI, 1 ISIN is mapped to this entity in the GLEIF cross-reference files.
No direct accounting-consolidating parent is reported, because no parent prepares consolidated accounts that include it. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.
No ultimate accounting-consolidating parent is reported, because no parent prepares consolidated accounts that include it. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.
The LEI registration is lapsed, and the entity status (active) records whether the legal entity itself still exists. The two are independent: an LEI can lapse while the company trades on, and it can stay issued after the company has been dissolved.
The mesh
Related entities
Source: GLEIF (CC0)Official record ↗More in United States